alphaveDRREDDY₹1,141.00

Dr. Reddy's Laboratories Ltd.

₹ CrorePeersSUNPHARMA CIPLA LUPIN APOLLOHOSP MAXHEALTH DIVISLAB TORNTPHARM ZYDUSLIFEMcap ₹95,274 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	6,248.7	7,298.4	10,077.8	10,077.8
+ Capital Work-in-Progress	1,351.0	2,399.4	1,460.2	1,460.2
+ Goodwill	550.1	1,313.9	1,479.7	1,479.7
+ Other Intangibles	3,626.8	9,614.1	10,505.8	10,505.8
+ Intangibles under Development	68.3	66.2	0.0	0.0
+ Investments (Equity Method)	419.6	481.1	567.3	567.3
+ Non-current Investments	105.9	239.3	894.2	894.2
+ Other Non-current Financial Assets	121.2	887.5	291.7	291.7
Non-current Financial Assets	227.1	1,126.8	1,185.9	1,185.9
+ Deferred Tax Assets	1,057.8	1,832.5	2,219.0	2,219.0
+ Other Non-current Assets	509.1	276.1	448.4	448.4
Total Non-current Assets	14,058.5	24,408.5	27,944.1	27,944.1
Current Assets
+ Inventories	6,355.2	7,108.5	7,653.4	7,653.4
+ Current Investments	4,405.0	3,330.7	3,823.3	3,823.3
+ Trade Receivables	8,029.8	9,042.0	10,123.4	10,123.4
+ Cash & Cash Equivalents	710.7	1,465.4	1,536.8	1,536.8
+ Other Bank Balances	1,017.0	994.8	1,811.9	1,811.9
+ Other Current Financial Assets	2,269.6	369.9	2,241.0	2,241.0
Current Financial Assets	16,432.1	15,202.8	19,536.4	19,536.4
+ Other Current Assets	2,018.0	2,706.8	2,989.5	2,989.5
Total Current Assets	24,805.3	25,018.1	30,179.3	30,179.3
Total Assets	38,863.8	49,426.6	58,123.4	58,123.4
Equity
+ Equity Share Capital	83.4	83.4	83.5	83.5
+ Other Equity / Reserves	28,171.4	33,466.2	37,808.0	37,808.0
Equity — Owners of Parent	28,254.8	33,549.6	37,891.5	37,891.5
+ Minority Interest	0.0	377.8	339.4	339.4
Total Equity	28,254.8	33,927.4	38,230.9	38,230.9
Liabilities
+ Borrowings — Non-current	380.0	380.0	0.0	0.0
+ Other Non-current Financial Liab	219.0	426.2	1,263.5	1,263.5
Non-current Financial Liabilities	599.0	806.2	1,263.5	1,263.5
+ Provisions — Non-current	23.9	29.8	33.8	33.8
+ Deferred Tax Liabilities	84.1	1,403.8	1,546.7	1,546.7
+ Other Non-current Liabilities	314.0	225.6	301.1	301.1
Non-current Liabilities	1,021.0	2,465.4	3,145.1	3,145.1
+ Borrowings — Current	1,272.3	3,804.5	6,293.5	6,293.5
+ Trade Payables	2,614.4	2,647.8	3,037.9	3,037.9
+ Other Current Financial Liab	3,631.5	4,184.1	4,918.6	4,918.6
Current Financial Liabilities	7,518.2	10,636.4	14,250.0	14,250.0
+ Provisions — Current	692.0	775.6	870.0	870.0
+ Current Tax Liabilities	234.1	302.8	435.3	435.3
+ Other Current Liabilities	1,143.7	1,319.0	1,192.1	1,192.1
Current Liabilities	9,588.0	13,033.8	16,747.4	16,747.4
Total Liabilities	10,609.0	15,499.2	19,892.5	19,892.5
Total Equity & Liabilities	38,863.8	49,426.6	58,123.4	58,123.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	28.2	21.0	33.4	33.4
+ Dues to Other Creditors — Current	2,586.2	2,626.8	3,004.5	3,004.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.